Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MMS Stock Forecast 2026-2027
$62.28
Current Price
$3.27B
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MMS Price Targets
+100.7%
To High Target of $125.00
+68.6%
To Median Target of $105.00
+36.5%
To Low Target of $85.00
MMS Price Momentum
+2.9%
1 Week Change
+4.8%
1 Month Change
-10.8%
1 Year Change
-27.8%
Year-to-Date Change
-37.7%
From 52W High of $100.00
+9.4%
From 52W Low of $56.92
📊 TOP ANALYST CALLS
Did MMS Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if MAXIMUS is one of their latest high-conviction picks.
Latest MMS Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, MMS has a bullish consensus with a median price target of $105.00 (ranging from $85.00 to $125.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $62.28, the median forecast implies a 68.6% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MMS Analyst Ratings
2
Buy
0
Hold
0
Sell
MMS Price Target Range
Low
$85.00
Average
$105.00
High
$125.00
Current: $62.28
Latest MMS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MMS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 2, 2025 | Raymond James | Brian Gesuale | Outperform | Upgrade | $90.00 |
| Jan 3, 2024 | Raymond James | Market Perform | Downgrade | $N/A | |
| Aug 18, 2023 | Stifel | Buy | Initiates | $N/A | |
| Feb 9, 2023 | Raymond James | Outperform | Maintains | $N/A | |
| May 6, 2022 | Raymond James | Outperform | Maintains | $N/A | |
| Jun 28, 2021 | Raymond James | Outperform | Downgrade | $N/A | |
| May 7, 2021 | Raymond James | Strong Buy | Maintains | $N/A | |
| Apr 22, 2021 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Feb 5, 2021 | Raymond James | Strong Buy | Maintains | $N/A | |
| Aug 7, 2020 | Keybanc | Overweight | Maintains | $N/A | |
| Aug 7, 2020 | KeyBanc | Overweight | Maintains | $N/A | |
| Jul 8, 2020 | Raymond James | Strong Buy | Upgrade | $N/A | |
| Jun 24, 2020 | Keybanc | Overweight | Upgrade | $N/A | |
| Jun 24, 2020 | KeyBanc | Overweight | Upgrade | $N/A | |
| Jan 8, 2020 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Aug 13, 2019 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Aug 9, 2019 | Wells Fargo | Market Perform | Downgrade | $N/A | |
| Oct 10, 2018 | Canaccord Genuity | Hold | Maintains | $N/A | |
| May 11, 2018 | Canaccord Genuity | Hold | Maintains | $N/A | |
| May 8, 2018 | First Analysis | Overweight | Upgrade | $N/A |
Maximus Inc. (MMS) Competitors
The following stocks are similar to MAXIMUS based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Maximus Inc. (MMS) Financial Data
Maximus Inc. has a market capitalization of $3.27B with a P/E ratio of 9.3x. The company generates $5.32B in trailing twelve-month revenue with a 7.0% profit margin.
Revenue growth is -4.1% quarter-over-quarter, while maintaining an operating margin of +11.4% and return on equity of +22.2%.
Valuation Metrics
Market Cap
$3.27B
Enterprise Value
$4.73B
P/E Ratio
9.3x
PEG Ratio
1.4x
Price/Sales
0.6x
Growth & Margins
Revenue Growth (YoY)
-4.1%
Gross Margin
+26.2%
Operating Margin
+11.4%
Net Margin
+7.0%
EPS Growth
+1.5%
Financial Health
Cash/Price Ratio
+4.8%
Current Ratio
2.2x
Debt/Equity
95.9x
ROE
+22.2%
ROA
+8.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Maximus Inc. (MMS) Business Model
About Maximus Inc.
What They Do
Provides health and human services to governments.
Business Model
Maximus Inc. generates revenue by offering business process services and consultancy to government programs. They focus on administrative solutions that enhance the delivery of healthcare, welfare, and employment services, particularly in programs like Medicaid and Medicare. Their expertise in managing complex processes and technology infrastructures allows them to optimize efficiency for public sector clients.
Additional Information
Headquartered in Reston, Virginia, Maximus has a global presence and plays a crucial role in ensuring compliance with regulatory standards while enhancing citizen engagement. The company's strategic approach to improving access to essential services contributes significantly to public health and economic resilience.
Company Information
Sector
Industrials
Industry
Specialty Business Services
Employees
37,200
CEO
Mr. Bruce L. Caswell
Country
United States
IPO Year
1997
Website
www.maximus.comMaximus Inc. (MMS) Latest News & Analysis
Latest News
Maximus Q2 Earnings Call Highlights
1 month ago
Quick Summary
Maximus (NYSE: MMS) raised its fiscal 2026 earnings outlook for the second straight quarter, citing stronger profitability, operational efficiencies from AI, and increased share buybacks.
Why It Matters
Maximus raising its fiscal 2026 earnings outlook signals strong profitability and efficient operations, potentially boosting investor confidence and share prices.
Source: MarketBeat
Market Sentiment:
Positive
Quick Summary
MMS exceeded Q2 EPS estimates and raised fiscal 2026 earnings guidance, but shares dropped due to decreased revenues from lower disaster support work.
Why It Matters
MMS's EPS beat suggests strong profitability, but declining revenues due to reduced disaster support may signal future challenges, impacting investor confidence and stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Maximus, Inc. (MMS) reported its Q2 2026 earnings, providing insights into financial performance and future outlook. For detailed figures and analysis, refer to the full earnings call transcript.
Why It Matters
Maximus, Inc.'s Q2 2026 earnings report provides insights into financial performance, growth potential, and market positioning, influencing investment decisions and stock valuations.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Maximus has released its financial results for the three and six months ending March 31, 2026. Further details on performance metrics are pending.
Why It Matters
Maximus' financial results can indicate performance trends, revenue growth, or market challenges, affecting investor sentiment and stock valuation.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Maximus (MMS) reported revenue and EPS for Q1 2026; investors should compare these metrics against Wall Street estimates and year-over-year performance for insights.
Why It Matters
Maximus' revenue and EPS relative to Wall Street estimates and prior year figures indicate its financial health and growth potential, influencing investor sentiment and stock valuation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Maximus (MMS) Q2 Earnings Beat Estimates
1 month ago
Quick Summary
Maximus (MMS) reported Q3 earnings of $2.07 per share, exceeding estimates of $1.98 and up from $2.01 per share a year earlier.
Why It Matters
Maximus' earnings beat estimates and show year-over-year growth, indicating strong performance and potentially positive stock momentum, impacting investor confidence and market perception.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About MMS Stock
What is Maximus Inc.'s (MMS) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Maximus Inc. (MMS) has a median price target of $105.00. The highest price target is $125.00 and the lowest is $85.00.
Is MMS stock a good investment in 2026?
According to current analyst ratings, MMS has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $62.28. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MMS stock?
Wall Street analysts predict MMS stock could reach $105.00 in the next 12 months. This represents a 68.6% increase from the current price of $62.28. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Maximus Inc.'s business model?
Maximus Inc. generates revenue by offering business process services and consultancy to government programs. They focus on administrative solutions that enhance the delivery of healthcare, welfare, and employment services, particularly in programs like Medicaid and Medicare. Their expertise in managing complex processes and technology infrastructures allows them to optimize efficiency for public sector clients.
What is the highest forecasted price for MMS Maximus Inc.?
The highest price target for MMS is $125.00 from at , which represents a 100.7% increase from the current price of $62.28.
What is the lowest forecasted price for MMS Maximus Inc.?
The lowest price target for MMS is $85.00 from at , which represents a 36.5% increase from the current price of $62.28.
What is the overall MMS consensus from analysts for Maximus Inc.?
The overall analyst consensus for MMS is bullish. Out of 2 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $105.00.
How accurate are MMS stock price projections?
Stock price projections, including those for Maximus Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 13, 2026 10:24 AM UTC